Z2B-21162-88252 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-17
Dose 1 — Pfizer-BioNTech
2021-04-07
Dose 2 — Pfizer-BioNTech
2021-05-06
Registered in v-safe
2021-05-06
Survey response — day 28, dose 2
MedDRA: Blister, Injection site erythema, Injection site mass, Injection site pain, Injection site pruritus, Injection site rash, Pain in extremity, Pruritus, Rash, Rash pruritic, Rash vesicular, Urticaria — Feeling: Fair · Be unable to do your normal daily activities

Free text: 20 days after 2nd dose, I had a sm. Grape size lump at injection site appears where CG was painful, itching and a rash. 23 days after 2nd dose a hive rash, blisters on my feet appeared and was itchy and painful, went away on day 26 after 2nd dose.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-12
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-05-19
Survey response — day 42, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair

Free text: Swollen glands in my under arm

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2022-04-07
Survey response — 12 months, dose 2
MedDRA: Breast tenderness, Heavy menstrual bleeding, Menstruation irregular — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Week after booster my breast were very tender- started menstruating again after already stopped for a year. It has been 87 days of non stop bleeding.

MedDRA releases: 2024-11 · check-in free text available
2022-04-07
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-04-12
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-17	Pfizer-BioNTech
2	2021-04-07	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-04-07	Unsuccessful

Free text

Release 8 — day 28, dose 2

2021-05-06

Symptoms: 20 days after 2nd dose, I had a sm. Grape size lump at injection site appears where CG was painful, itching and a rash. 23 days after 2nd dose a hive rash, blisters on my feet appeared and was itchy and painful, went away on day 26 after 2nd dose. cut off by CDC

Release 8 — day 42, dose 2

2021-05-19

Symptoms: Swollen glands in my under arm

Release 11 — 12 months, dose 2

2022-04-07

Symptoms: Week after booster my breast were very tender- started menstruating again after already stopped for a year. It has been 87 days of non stop bleeding.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Blister	✓	·	✓
SD	Breast tenderness	·	·	✓
SD	Heavy menstrual bleeding	·	·	✓
SD	Injection site erythema	○	✓	○
SD	Injection site mass	✓	✓	✓
SD	Injection site pain	✓	✓	✓
SD	Injection site pruritus	✓	✓	✓
SD	Injection site rash	✓	✓	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Menstruation irregular	·	·	✓
SD	Pain in extremity	✓	·	✓
SD	Pruritus	✓	·	✓
SD	Rash	○	✓	○
SD	Rash pruritic	○	✓	○
SD	Rash vesicular	○	✓	○
SD	Urticaria	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release